SEC Form 4 · accession 0001140361-15-035062
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sue Bailey
Director
Period of report
Sep 11, 2015
Accepted (ET)
Sep 15, 2015 · 3:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 11, 2015 | M | 1,440 | $8.43 | A | 29,940 | D | |
| Common StockF1 | Sep 11, 2015 | S | 1,440 | $32.49 | D | 28,500 | D | |
| Common StockF2 | Sep 11, 2015 | M | 4,640 | $8.76 | A | 33,140 | D | |
| Common StockF2 | Sep 11, 2015 | S | 4,640 | $32.33 | D | 28,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $8.43 | Sep 11, 2015 | M | 1,440 | D | Jun 13, 2010 | Jun 13, 2017 | Common Stock | 1,440 | 0 | D |
| Stock OptionF2 | $8.76 | Sep 11, 2015 | M | 4,640 | D | May 20, 2011 | May 20, 2018 | Common Stock | 4,640 | 0 | D |
Explanation of responses
- F1Consists of an option granted under the company's stock incentive plan on June 14, 2007.
- F2Consists of an option granted under the company's stock incentive plan on May 21, 2008.